Cargando…
Hypothesis: Nasal vs. oral inhalation accounts for the severity of COVID-19
Autor principal: | Komisaruk, Barry R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467121/ https://www.ncbi.nlm.nih.gov/pubmed/33254545 http://dx.doi.org/10.1016/j.mehy.2020.110239 |
Ejemplares similares
-
Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
por: Mehta, Piyush Pradeep, et al.
Publicado: (2023) -
Nasally inhaled therapeutics and vaccination for COVID‐19: Developments and challenges
por: Xi, Jinxiang, et al.
Publicado: (2021) -
Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
por: Magoon, Rohan, et al.
Publicado: (2021) -
La ciencia del orgasmo : la naturaleza humana y los mecanismos del placer /
por: Komisaruk, Barry R.
Publicado: (2008) -
Letter to the Editor: “Use of inhaled epoprostenol with high flow nasal oxygen in non-intubated patients with severe COVID-19”
por: Chiles, Joe W., et al.
Publicado: (2022)